Stenosis

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.

August 22, 2014

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J. 2014 Aug 22, Breithardt G1, Baumgartner H2, Berkowitz SD3, Hellkamp AS4, Piccini JP4, Stevens SR4, Lokhnygina Y4, Patel MR4, Halperin JL5, Singer DE6, Hankey GJ7,Hacke W8, Becker RC4, Nessel CC9, Mahaffey KW10, Fox KA11, Califf RM12; for the ROCKET AF Steering Committee & […]